Correspondence 0001213900-24-096417 from Onconetix, Inc. (ONCO)

Onconetix, Inc.
Date: Nov. 12, 2024 · CIK: 0001782107 · Accession: 0001213900-24-096417

View on Edgar

AI Filing Summary & Sentiment

Sentiment

Urgency

Document Type

Confidence

SEC Posture

Company Posture

Summary

Reasoning

File numbers found in text: 333-282958

Date

November 12, 2024

Author

/s/ Ralph Schiess

Form

CORRESP

Company

Onconetix, Inc.

Letter

Onconetix, Inc.

201 E. Fifth Street, Suite 1900

Cincinnati, OH 45202

VIA EDGAR

November 12, 2024

U.S. Securities and Exchange Commission

Office of Life Sciences

Washington, D.C. 20549

Attn: Joshua Gorsky, Tim Buchmiller

Re:

Onconetix, Inc.

Registration Statement on Form S-1

Filed November 1, 2024

File No. 333-282958

Ladies and Gentleman,

Pursuant to Rule 461 under the Securities Act of 1933, as amended, Onconetix, Inc. hereby requests acceleration of effectiveness of the above referenced Registration Statement so that it will become effective at 4:00 p.m. EST on Tuesday, November 12, 2024, or as soon as thereafter practicable.

Very truly yours,
/s/ Ralph Schiess

Show Raw Text

CORRESP
1
filename1.htm

Onconetix, Inc.

201 E. Fifth Street, Suite 1900

Cincinnati, OH 45202

VIA EDGAR

November 12, 2024

U.S. Securities and Exchange Commission

Office of Life Sciences

Washington, D.C. 20549

Attn: Joshua Gorsky, Tim Buchmiller

    Re:

    Onconetix, Inc.

    Registration Statement on Form S-1

    Filed November 1, 2024

    File No. 333-282958

Ladies and Gentleman,

Pursuant to Rule 461 under the
Securities Act of 1933, as amended, Onconetix, Inc. hereby requests acceleration of effectiveness of the above referenced Registration
Statement so that it will become effective at 4:00 p.m. EST on Tuesday, November 12, 2024, or as soon as thereafter practicable.

    Very truly yours,

    /s/ Ralph Schiess

    By: Ralph Schiess

    Title: Interim Chief Executive Officer

    cc:

    Ellenoff Grossman & Schole LLP

SecProbe.io